Overview
- Rocket Lab shares fell roughly 11% after SpaceX’s June 12 IPO, a move traders said shifted short-term capital to the larger new public competitor and drove recent selling pressure.
- The company will join the Nasdaq‑100 before the open on June 22, which forces passive funds that track the index to buy RKLB shares and may provide mechanical demand for the stock.
- Operational fundamentals remain strong with a record Q1 revenue near $200 million, a roughly $2.2 billion backlog that management expects to convert into revenue over coming quarters, and secured defense work including a $190 million HASTE contract and a passed SDA System Requirements Review for Lightning satellites.
- Investors worry the stock trades at an elevated multiple — analysts and commentators cite roughly 65 times sales — and Rocket Lab’s standing at‑the‑market equity facility raises dilution risk if the company chooses to issue shares to fund growth.
- The next key tests for investor confidence are technical progress on the reusable Neutron medium‑lift rocket, now targeting a late‑2026 first flight, the company’s funding choices around the ATM, and whether index inflows outweigh valuation-driven selling.